Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
TG Therapeutics, Inc.
(OB:
TGTX
)
6.570
USD
UNCHANGED
Last Price
/ Updated:
8:10 PM EDT, May 29, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
6.570
Today's Range
6.570 - 6.570
52wk Range
3.800 - 6.730
Shares Outstanding
26,322,671
Dividend Yield
N/A
Performance
YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
+70.21%
+70.21%
Top News
More News
TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results and Business Update
March 05, 2014
Investor Conference Call to Be Held Thursday, March 6, 2014 at 8:30am ET
Read More
from
GlobeNewswire News Releases
TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2013 Financial Results and Business Update
March 04, 2014
Investor Conference Call to be Held Thursday, March 6, 2014 at 8:30am ET
Read More
from
GlobeNewswire News Releases
More News
Read More
TG Therapeutics, Inc. to Present at the 16th Annual BIO CEO & Investor Conference
February 07, 2014
from
GlobeNewswire News Releases
TG Therapeutics, Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference
January 13, 2014
from
GlobeNewswire News Releases
Coronado Biosciences Announces Management Changes
December 20, 2013
from
GlobeNewswire News Releases
TG Therapeutics, Inc. Announces Presentation of Encouraging Clinical Activity of TGR-1202 in an Ongoing Multi-Center Phase I Clinical Study
December 09, 2013
from
GlobeNewswire News Releases
TG Therapeutics, Inc. Launches Combination Clinical Trial of TG-1101 and Ibrutinib in Patients With Select B-Cell Malignancies
December 06, 2013
from
GlobeNewswire News Releases
TG Therapeutics, Inc. Announces Poster Presentations for TGR-1202 at the Upcoming 55th American Society of Hematology Meeting
December 05, 2013
from
GlobeNewswire News Releases
TG Therapeutics, Inc. to Present at the 2013 Deutsche Bank BioFEST Conference
November 26, 2013
from
GlobeNewswire News Releases
Is It Too Late to Buy the Rally in Small Caps?
March 07, 2014
category
NASDAQ:INSY
,
NYSEARCA:UWM
,
NASDAQ:TGTX
, and 11 more.
from
InvestorPlace - Latest Headlines
TG Therapeutics, Inc. (TGTX) Posts Q4 Loss of 19c/Share
March 05, 2014
from
StreetInsider.com News Articles
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here